ConductScience.org, home

Paper28697342

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.

Wang Q and 33 others. Cancer Cell, 2017. Cited by 1,472 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Papers, record 28697342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28697342

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.
PubMed
Journal
Cancer Cell
PubMed
Year
2017
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
1,472
iCite
Relative citation ratio, by iCite
47.3
iCite
Revised in PubMed
2024-01-04
PubMed

Authors34

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang QQianghu
2Hu BBaoli
3Hu XXin
4Kim HHoon
5Squatrito MMassimo
6Scarpace LLisa
7deCarvalho ACAna C
8Lyu SSali
9Li PPengping
10Li YYan
11Barthel FFloris
12Cho HJHee Jin
13Lin YHYu-Hsi
14Satani NNikunj
15Martinez-Ledesma EEmmanuel
16Zheng SSiyuan
17Chang EEdward
18Sauvé CGCharles-Etienne Gabriel
19Olar AAdriana
20Lan ZDZheng D

Source PubMed

See all 34 authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gene Expression Regulation, NeoplasticMajor topic
GlioblastomaMajor topic
Tumor MicroenvironmentMajor topic
Gene Expression Profiling
Humans
Phenotype
Recurrence
Survival Analysis
T-Lymphocytes

Source PubMed

Grants9

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA120813NCI NIH HHSUnited StatesR01CA120813PubMed and NIHNIH RePORTER
P30 CA016672NCI NIH HHSUnited StatesP30CA016672PubMed and NIHNIH RePORTER
R01 CA190121NCI NIH HHSUnited StatesR01CA190121PubMed and NIHNIH RePORTER
P30 CA034196NCI NIH HHSUnited StatesP30CA034196PubMed and NIHNIH RePORTER
K99 CA194289NCI NIH HHSUnited StatesK99CA194289PubMed and NIHNIH RePORTER
R00 CA194289NCI NIH HHSUnited StatesK99CA194289PubMed and NIHNIH RePORTER
P50 CA097257NCI NIH HHSUnited StatesP50CA097257PubMed and NIHNIH RePORTER
P50 CA127001NCI NIH HHSUnited StatesP50CA127001PubMed and NIHNIH RePORTER
R00CA194289NIHNIH RePORTER

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in29,316,430Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.https://conductscience.org/library/papers/29316430

Source PubMed

References71

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128,031,383GlioVis data portal for visualization and analysis of brain tumor expression datasets.Neuro Oncol2017https://conductscience.org/library/papers/28031383PubMed
217,288,599Improved precision and accuracy for microarrays using updated probe set definitions.BMC Bioinformatics2007https://conductscience.org/library/papers/17288599PubMed
319,193,730A single-sample method for normalizing and combining full-resolution copy numbers from multiple platforms, labs and analysis methods.Bioinformatics2009https://conductscience.org/library/papers/19193730PubMed
423,558,169An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.Science2013https://conductscience.org/library/papers/23558169PubMed
512,066,192Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review).Oncol Rep2002https://conductscience.org/library/papers/12066192PubMed
623,079,654Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.Cancer Cell2012https://conductscience.org/library/papers/23079654PubMed
725,858,805Macrophages and therapeutic resistance in cancer.Cancer Cell2015https://conductscience.org/library/papers/25858805PubMed
821,135,147Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy.Clin Cancer Res2011https://conductscience.org/library/papers/21135147PubMed
919,427,294Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.Cell Stem Cell2009https://conductscience.org/library/papers/19427294PubMed
1025,691,693Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas.Neuro Oncol2015https://conductscience.org/library/papers/25691693PubMed
1125,114,226MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/25114226PubMed
1226,973,881Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.JCI Insight2016https://conductscience.org/library/papers/26973881PubMed
1316,618,716A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy.Cancer Res2006https://conductscience.org/library/papers/16618716PubMed
1424,113,773Inferring tumour purity and stromal and immune cell admixture from expression data.Nat Commun2013https://conductscience.org/library/papers/24113773PubMed
1524,695,405PRADA: pipeline for RNA sequencing data analysis.Bioinformatics2014https://conductscience.org/library/papers/24695405PubMed
1624,457,416Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge.Nat Rev Cancer2014https://conductscience.org/library/papers/24457416PubMed
1722,290,264Studying a complex tumor: potential and pitfalls.Cancer J2012https://conductscience.org/library/papers/22290264PubMed
1827,001,570Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.J Clin Oncol2016https://conductscience.org/library/papers/27001570PubMed
1924,925,914Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.Science2014https://conductscience.org/library/papers/24925914PubMed
2016,530,701Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.Cancer Cell2006https://conductscience.org/library/papers/16530701PubMed

See all 71 references

Cited by1,237

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,472 citations.

PMIDTitleJournalYearIn PapersSource
42,989,284IFN-γ signaling drives multiple immunosuppressive pathways and poor clinical outcome in glioblastoma.BMC Med2026https://conductscience.org/library/papers/42989284PubMed
42,983,003Ex vivo therapy-driven selection of glioblastoma stem-like cells models resistance evolution.EMBO Mol Med2026https://conductscience.org/library/papers/42983003PubMed
42,978,985Lactylation in glioblastoma: mechanisms and therapeutic perspectives.Front Cell Dev Biol2026https://conductscience.org/library/papers/42978985PubMed
42,948,477Dynamics of IDH1 Mutation and Protein Expression Between Primary and Recurrent Gliomas and Their Prognostic Significance.Hum Mutat2026https://conductscience.org/library/papers/42948477PubMed
42,940,022Cross-Cancer Characterization of CAMK2A Reveals Its Favorable Prognostic Association and Neuronal Signature Enrichment in Glioma.Biomedicines2026https://conductscience.org/library/papers/42940022PubMed
42,936,333Spatial heterogeneity in glioblastoma: linking single-cell and spatial multi-omics to vaccine immunotherapy.Front Immunol2026https://conductscience.org/library/papers/42936333PubMed
42,930,194Nuclear Eccentricity as a Potential Biomarker for Tumor Biology and Survival in Glioblastoma.Curr Oncol2026https://conductscience.org/library/papers/42930194PubMed
42,922,526Ex vivo glioblastoma migration phenotypes define clinical recurrence and tumor heterogeneity.bioRxiv2026https://conductscience.org/library/papers/42922526PubMed
42,919,388Blood-brain barrier and blood-tumoral barrier formation in glioblastoma: endothelial cells and glioblastoma stem cells at the immune-brain crossroad.Fluids Barriers CNS2026https://conductscience.org/library/papers/42919388PubMed
42,911,458Advances in Single-Cell and Spatial Omics for Glioblastoma Precision Medicine.Curr Oncol Rep2026https://conductscience.org/library/papers/42911458PubMed
42,910,261Immune subtypes and survival in patients with primary glioma.Neurooncol Adv2026https://conductscience.org/library/papers/42910261PubMed
42,891,017A re-visit of glioblastoma molecular subtypes utilizing the 2021 WHO classification of central nervous system tumors framework.Neurooncol Adv2026https://conductscience.org/library/papers/42891017PubMed
42,869,880Stanniocalcin 1 contributes to glioma stem cells phenotypic plasticity through NOTCH1/STAT3/GFPT2 axis.Oncogenesis2026https://conductscience.org/library/papers/42869880PubMed
42,866,269M2 type tumor-associated macrophage-derived CCL-18 promotes glioma cell proliferation but does not mediates glioma recurrence after radiotherapy.iScience2026https://conductscience.org/library/papers/42866269PubMed
42,860,508Low-Density Lipoprotein Receptor-Targeted Biomimetic Nanoplatform Suppresses Glioblastoma Stemness and Remodels Antitumor Immunity via Dual Metabolic Disruption.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42860508PubMed
42,818,949Spatial Proteomics and Epigenomics Reveal Cell Morphology and Epigenetic Gene Regulation in Human Hippocampus.Res Sq2026https://conductscience.org/library/papers/42818949PubMed
42,749,405Investigating the prognostics and theranostic cell cycle-related genes of Hinokinin in high-grade glioma: an integrated network pharmacology, bioinformatics, and molecular docking approach.J Genet Eng Biotechnol2026https://conductscience.org/library/papers/42749405PubMed
42,742,779Immune-related hallmark pathway heterogeneity identifies a prognostic risk signature with independent external validation in glioblastoma.Discov Oncol2026https://conductscience.org/library/papers/42742779PubMed
42,683,315The ERK MAPK pathway in mesenchymal glioblastoma: tumorigenesis, microenvironmental reprogramming, and the therapeutic promise of RAS(ON) multi-selective inhibition.Front Mol Neurosci2026https://conductscience.org/library/papers/42683315PubMed
42,661,193Spatial enrichment of PTPRZ1 in the peritumoral niche drives glioblastoma migration via the OPA1/ROS/CDH2 axis.J Transl Med2026https://conductscience.org/library/papers/42661193PubMed

See all 1,237 cited by

Genes19

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AIF1199PubTator's text mininghttps://conductscience.org/library/genes/199NCBI Gene
CD14929PubTator's text mininghttps://conductscience.org/library/genes/929NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CTLA41,493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
EGF1,950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene
EGFR1,956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
FGF22,247PubTator's text mininghttps://conductscience.org/library/genes/2247NCBI Gene
GFAP2,670PubTator's text mininghttps://conductscience.org/library/genes/2670NCBI Gene
IDH13,417PubTator's text mininghttps://conductscience.org/library/genes/3417NCBI Gene
ITGAM3,684PubTator's text mininghttps://conductscience.org/library/genes/3684NCBI Gene
MRAP56,246PubTator's text mininghttps://conductscience.org/library/genes/56246NCBI Gene
NF14,763PubTator's text mininghttps://conductscience.org/library/genes/4763NCBI Gene
NFASC23,114PubTator's text mininghttps://conductscience.org/library/genes/23114NCBI Gene
NFKB14,790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
PTEN5,728PubTator's text mininghttps://conductscience.org/library/genes/5728NCBI Gene
RPL396,170PubTator's text mininghttps://conductscience.org/library/genes/6170NCBI Gene
TP537,157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene
VCL7,414PubTator's text mininghttps://conductscience.org/library/genes/7414NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28697342

GET https://conductscience.org/api/papers/v1/28697342/authors?page=2